Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DETECT: Coreg CR and Lisinopril in Early Cardiovascular Disease
NCT00553969Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Nov 2007
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of carvedilol in prehypertension and cardiovascular disease (CVD) (4 arms), sponsored by University of Minnesota. Primary endpoint: Change in Rasmussen Disease Score at 9 months. Started Nov 2007; status: completed.
02
Drugs
carvedilol
03
Conditions
prehypertensioncardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT00553969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553969.